Table 2.
Immunohistochemistry in myeloid sarcoma
| Immunohistochemical stains | Rates of positivity (%) | References |
|---|---|---|
| CD68/KP1 | 90–100 | [13, 65, 66] |
| CD33 | 55–94 | [66, 67] |
| CD43 | 9–100 | [66, 67] |
| MPO | 50–88 | [13, 65, 66] |
| Lysozyme | 23–92 | [66, 67] |
| HLA-DR | 41–86 | [13, 65, 67] |
| CD117 | 55–80 | [13, 67] |
| CD99 | 56 | [13] |
| CD68/PG-M1 | 51–53 | [13, 65] |
| CD34 | 27–44 | [13, 65, 67] |
| CD56 | 5–30 | [13, 65–67] |
| TdT | 0–32 | [13, 66] |
| CD163 | 30 | [66] |
| CD123 | 23 | [66] |
| CD4 | 1–22 | [13, 66, 67] |
| CD14 | 13 | [66] |
| CD30 | 2 | [13] |
| BCL-2 | 80 | [69, 70] |